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Abstract. 
 
Intracellular propulsion of 
 
Listeria monocy-
togenes
 
 is the best understood form of motility depen-
dent on actin polymerization. We have used in vitro 
motility assays of 
 
Listeria
 
 in platelet and brain extracts 
to elucidate the function of the focal adhesion proteins 
of the Ena (
 
Drosophila
 
 Enabled)/VASP (vasodilator-
stimulated phosphoprotein) family in actin-based mo-
tility. Immunodepletion of VASP from platelet extracts 
and of Evl (Ena/VASP-like protein) from brain extracts 
of Mena knockout (
 
2
 
/
 
2
 
) mice combined with add-
back of recombinant (bacterial or eukaryotic) VASP 
and Evl show that VASP, Mena, and Evl play inter-
changeable roles and are required to transform actin 
polymerization into active movement and propulsive 
force. The EVH1 (Ena/VASP homology 1) domain of 
VASP is in slow association–dissociation equilibrium 
high-afﬁnity binding to the zyxin-homologous, proline-
rich region of ActA. VASP also interacts with F-actin 
via its COOH-terminal EVH2 domain. Hence VASP/
Ena/Evl link the bacterium to the actin tail, which is re-
quired for movement. The afﬁnity of VASP for F-actin 
is controlled by phosphorylation of serine 157 by 
cAMP-dependent protein kinase. Phospho-VASP binds 
with high afﬁnity (0.5 
 
3
 
 10
 
8
 
 M
 
2
 
1
 
); dephospho-VASP 
binds 40-fold less tightly. We propose a molecular 
ratchet model for insertional polymerization of actin, 
within which frequent attachment–detachment of 
VASP to F-actin allows its sliding along the growing ﬁl-
ament.
Key words: actin polymerization • 
 
Listeria monocy-
togenes
 
 • Ena/VASP/Mena • motility • platelet
 
s
 
T
 
HE
 
 intracellular pathogenic bacterium 
 
Listeria mono-
cytogenes
 
 can propel itself in the host cytoplasm.
The propulsive force is thought to be generated by
the polymerization of actin filaments (Tilney and Portnoy,
1989; Dabiri et al., 1990; Tilney et al., 1990; Sanger et al.,
1992; Theriot et al., 1992), in a process mechanistically
similar to the actin-based protrusion of the lamellipodium
of locomoting cells (for review see Tilney and Tilney,
1993). The assembled filaments are organized in a mesh-
work or “tail” used by the bacterium as a support for pro-
pulsion. The successful in vitro reconstitution of 
 
Listeria
 
movement in 
 
Xenopus
 
 egg (Theriot et al., 1994; Marchand
et al., 1995) or platelet (Carlier et al., 1997; Welch et al.,
1997) extracts makes this bacterium a good experimental
model for the biochemical and physical approach of the
cellular factors responsible for actin assembly at the lead-
ing edge of motile cells.
In recent years, a combination of physical, genetic, and
biochemical approaches have led to the view that 
 
Listeria
 
movement is driven by the turnover of actin filaments
(Carlier et al., 1997; Rosenblatt et al., 1997). The growth of
barbed ends, restricted to the bacterium surface and initi-
ated by the bacterial protein ActA (Domann et al., 1992;
Kocks et al., 1992), is fed by the pointed end depolymer-
ization of filaments in the medium, including the ones that
form the actin tail attached to the bacterium. Hence, dur-
ing steady locomotion, the length of the actin tail is main-
tained constant. A Brownian ratchet mechanism (Mogil-
ner and Oster, 1996) has been proposed as a model for
actin-based motility of 
 
Listeria
 
, within which structural
fluctuations of the actin meshwork allow insertional poly-
merization of actin to push the bacterium in the direction
of growth of this meshwork.
The above description of 
 
Listeria
 
 movement implies
that many cell components are needed to generate motil-
ity. Proteins regulating actin dynamics such as capping
proteins, ADF/cofilin, and profilin play an important role
in enhancing filament turnover, i.e., in increasing the site-
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directed barbed end growth (Carlier, 1998; for review see
Didry et al., 1998). Proteins that cross-link actin filaments
such as alpha-actinin (Dold et al., 1994) organize the actin
tail in a rigid meshwork allowing the generation of force.
Recent reports have shown that a multiprotein complex,
isolated from platelet extracts, containing the actin-related
proteins Arp2 and Arp3, is sufficient to initiate actin poly-
merization at the surface of 
 
Listeria
 
 (Welch et al., 1997),
most likely by interacting with ActA (Welch et al., 1998).
The Arp2/3 complex remains bound to the pointed ends of
nucleated filaments and is uniformly distributed through-
out the actin tail while the bacterium is moving (Welch
et al., 1997). The existence of a critical concentration
for Arp2/3-capped pointed ends (Mullins et al., 1998) in-
dicates that monomer–polymer exchanges occur at the
capped ends. This is consistent with pointed end depoly-
merization in the tail and a filament half-life of 
 
z
 
1 min
(Theriot et al., 1992), except perhaps in the axial core of
long filaments forming protrusions (Sechi et al., 1997).
Strikingly, the actin meshwork assembled at the surface of
 
Listeria
 
 by Arp2/3 alone is unable to generate propulsion
of the bacterium. Therefore, crucial issues remain to be
solved to understand the molecular mechanism by which
the filaments are nucleated and remain attached while
growing at the bacterium surface, and how the spatial or-
ganization of the actin meshwork is achieved, as the fila-
ments grow, to produce force and movement. The targets
of the 
 
Listeria 
 
protein ActA clearly must play a role in es-
tablishing a dynamic link between polymerizing filaments
and the bacterium surface. Genetic studies have shown
that the 639–amino acid ActA protein, which is anchored
by its COOH-terminal region, to the bacterial membrane,
possesses two regions important for motility. The NH
 
2
 
-ter-
minal region (1–262) appears solely responsible for actin
nucleation (Pistor et al., 1995; Lasa et al., 1997). The cen-
tral domain (263–390), which contains four proline-rich re-
peats, also found in the cytoskeletal proteins vinculin and
zyxin (Reinhard et al., 1995), controls the rate of move-
ment (Pistor et al., 1995; Smith et al., 1996; Lasa et al.,
1997; Niebuhr et al., 1997). The proline-rich repeats of
ActA form the binding site for vasodilator-stimulated
phosphoprotein (VASP)
 
1
 
 or Mena, the only host proteins
thus far known to bind to ActA and to remain localized to
the bacterium–actin interface as 
 
Listeria
 
 is moving (Chak-
raborty et al., 1995; Gertler et al., 1996).
VASP and Mena belong to the Ena-VASP family of
proteins (Gertler et al., 1996) which share homology with
the
 
 Drosophila
 
 Enabled (Ena) protein, known to be in-
volved in neural development (Gertler et al., 1990, 1995).
These proteins localize at focal contacts and in regions
where actin filaments are highly dynamic (Gertler et al.,
1996). They are organized in three domains, an EVH1
(Ena-VASP-homology 1) NH
 
2
 
-terminal domain, a pro-
line-rich central domain, and an EVH2 COOH-terminal
domain. The EVH1 domain mediates the interaction of
VASP (Gertler et al., 1996; Niebuhr et al., 1997) and of
Mena, the murine homologue of Ena (Gertler et al., 1996),
with the proline-rich repeats of ActA. In mammalian cells,
 
proteins of the Ena/VASP family are thought to be tar-
geted to focal adhesions due to the interaction of their
EVH1 domain with the ActA-homologous proline-rich
motifs of zyxin (Reinhard et al., 1995; Gertler et al., 1996),
and may also similarly interact with vinculin (Brindle et al.,
1996; Gertler et al., 1996; Reinhard et al., 1996; Hüttel-
maier et al., 1998). VASP has also been shown to bind
F-actin (Reinhard et al., 1992). Ena/VASP proteins pos-
sess a proline-rich region, comprising a (GP
 
5
 
)
 
3
 
 sequence
(Haffner et al., 1995; Gertler et al., 1996) present as a sin-
gle or repeated motif in the different proteins. Profilin
binds VASP and Mena in vitro (Reinhard et al., 1995;
Gertler et al., 1996) and in cell extracts (Lambrechts et al.,
1997) probably via the (GP
 
5
 
)
 
3
 
 repeats (Reinhard et al.,
1995; Kang et al., 1997). Profilin actually binds the isolated
(GP
 
5
 
)
 
3
 
 peptide (Domke et al., 1997; Lambrechts et al.,
1997), consistent with its ability to bind to poly-
 
L
 
-proline.
The present work focuses on the role of VASP, Mena,
and Ena/VASP-like (Evl) proteins in the motility of 
 
Lis-
teria
 
 in platelet and brain extracts. Platelets are rich in
actin-binding proteins involved in motility and contain
micromolar amounts of VASP, whose phosphorylation by
cAMP- and cGMP-dependent kinases correlates with the
inhibition of platelet aggregation (Waldmann et al., 1987;
Aszodi et al., 1999), hence they represent a choice material
for the analysis of the mechanism of site-directed actin as-
sembly in response to signaling. Brain extracts are rich in
the Mena and Evl proteins. Motility assays have been per-
formed using immunodepleted and reconstituted platelet
extracts and brain extracts from wild-type and Mena knock-
out (
 
2
 
/
 
2
 
) mice, and combined with the use of peptide mi-
metics and with in vitro polymerization assays to explore
the function of VASP, Mena, and Evl in actin-based motil-
ity of 
 
Listeria
 
.
 
Materials and Methods
 
Proteins and Antibodies
 
Actin was purified from rabbit muscle (Spudich and Watt, 1971) and iso-
lated as Ca-ATP-G-actin by Sephadex G-200 chromatography (MacLean-
Fletcher and Pollard, 1980) in G buffer (5 mM Tris-Cl
 
2
 
, pH 7.8, 0.1 mM
CaCl
 
2
 
, 0.2 mM ATP, 1 mM DTT, 0.01% NaN
 
3
 
). Actin was pyrenyl-labeled
(Kouyama and Mihashi, 1981) or rhodamine-labeled on lysines in the F
form as described (Isambert et al., 1995). Profilin was purified from bo-
vine spleen as described (Pantaloni and Carlier, 1993).
VASP bacterial recombinant protein was expressed and purified as de-
scribed (Hüttelmaier et al., 1998).
For recombinant Evl protein, a fragment encoding amino acids 1–393
of Evl was generated via PCR and cloned in pFB-Nhis (GIBCO-BRL).
Recombinant protein was obtained and purified using the Bac-to-Bac™
baculovirus expression system (GIBCO-BRL) according to the manufac-
turer’s instructions. Recombinant baculovirus-infected high-five insect
cells were harvested and the recombinant protein purified by affinity to
Talon resin (Clontech) according to the manufacturer’s instructions. The
coding region of Evl was amplified for a cDNA using the following prim-
ers: forward primer: 5
 
9
 
-Cgg gAT CCA TgA gTg AAC AgA gTA TCT gC-3
 
9
 
,
reverse primer: 5
 
9
 
-Cgg Cgg CCg CCg Tgg TgC TgA TCC CAC-3
 
9
 
.
GST fusion proteins of EVH1 domains of Mena or Evl have been de-
scribed elsewhere (Gertler et al., 1996; Niebuhr et al., 1997). Fragments
encoding the EVH1 domain of VASP (amino acids 1–149) or the proline-
rich repeat region of ActA (amino acids 241–423) were generated by
PCR, and cloned into the pGEX2TK vector (Pharmacia). Prokaryotic re-
combinant GST-EVH2 (amino acids 226–380) was obtained by generating
the fragment from full-length VASP by PCR and cloning it into the
pGEX4T1 vector (Pharmacia). The GST fusion proteins were expressed
and purified following manufacturer’s instructions.
 
1. 
 
Abbreviations used in this paper:
 
 Ena, 
 
Drosophila
 
 Enabled protein;
VASP, vasodilator-stimulated phosphoprotein. 
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The monoclonal VASP antibody (clone IE245) used in this study was
described recently (Abel et al., 1996). The mAb against Evl (clone 84H1)
was raised against the GST fusion protein of Evl-EVH1, and specificity
was confirmed on pure Evl-EVH1 protein after thrombin digestion of the
GST fusion protein. Both antibodies are IgGs and have been purified by
affinity chromatography using protein G–Sepharose. The VASP poly-
clonal antibody M4 was purchased from Immunoglobe.
The (GP
 
5
 
)
 
3
 
 peptide of the VASP proline-rich region was synthesized
with an AMS 222 Multiple Sequencer using TentaGel S resin (Rapp Poly-
mere).
The creation and analysis of the Mena knockout mice is described in
Lanier et al. (1999).
 
Recombinant VASP Protein Construction and 
Expression in Insect Cells
 
The complete human VASP cDNA was PCR amplified from a clone
(I.M.A.G.E clone 824217) obtained at Genome System Inc., using the fol-
lowing two oligonucleotide primers: 5
 
9
 
-GCG ATA AGG ATC CGa tga
gcg aga cgg tca tct g-3
 
9
 
 and 5
 
9
 
-GCG CCT GGT ACC tca ggg aga acc ccg
ctt cc-3
 
9
 
. The pBlueBacHis2B-VASP plasmid was generated by ligating
the BamH1/Kpn1 double digest PCR fragment with the BamH1/Kpn1 di-
gested pBlueBacHis2 B (Invitrogen BV). The resulting polyhistidine-
enterokinase site NH
 
2
 
-terminal–tagged VASP nucleotide sequence was
verified by DNA sequencing.
Generation of the VASP recombinant baculovirus was achieved by us-
ing the standard procedure of transfection–recombination in Sf21 insect
cells (O’Reilly et al., 1992). Positive virus clones were identified by West-
ern blot analysis using both the M4 anti-VASP rabbit pAb or the anti-
Xpress™ mAb (Invitrogen BV).
Sf21 insect cells were cultured in Grace’s supplemented media
(GIBCO-BRL) containing 10% FBS (GIBCO-BRL) and 0.001% plu-
ronic acid (GIBCO-BRL) in 1 liter polycarbonate Erlenmeyer flask at
27
 
8
 
C under vigorous shaking. 250 ml of cell suspension (1.5–2.5 
 
3
 
 10
 
6
 
/ml)
was infected with the recombinant VASP baculovirus at a multiplicity of
infection ranging from 2 to 5 for 60 h.
 
Purification of Recombinant VASP from Sf21
Insect Cells
 
Harvested infected Sf21 cells were rinsed once in ice-cold PBS and dis-
rupted on ice in 10 ml of lysis buffer (20 mM sodium phosphate, pH 8.0,
5% glycerol, and 1 mM DTT) containing protease inhibitors (0.5 mM
PMSF, 10 
 
m
 
g/ml benzamidine, 5 
 
m
 
g/ml chymostatin, and 5 
 
m
 
g/ml leupep-
tin). The mixture was centrifuged for 20 min at 45,000 
 
g
 
 at 4
 
8
 
C. The super-
natant was kept on ice. The pellet was resuspended in 10 ml of buffer A
(20 mM sodium phosphate, pH 8.0, 300 mM NaCl, 5% glycerol, 0.03%
Tween 20, 1 mM DTT, and protease inhibitors), homogenized in a
Dounce potter, and left on ice for 30 min before a 20-min centrifugation
run at 45,000 
 
g
 
 at 4
 
8
 
C. The supernatant was added to the first one and the
whole solution was dialyzed against 500 ml of 20 mM sodium phosphate,
pH 8.0, 5% glycerol, 0.03% Tween 20, and 1 mM DTT (two changes). The
cellular extract containing VASP was rapidly drop-frozen in liquid nitro-
gen and kept at 
 
2
 
80
 
8
 
C.
Purification of the insect recombinant VASP was achieved at 4
 
8
 
C by a
two-step chromatography procedure. The cellular extract was laid on a 10-ml
DEAE-cellulose matrix DE52 (Whatman) equilibrated with buffer B
(20 mM sodium phosphate, pH 8.0, 0.5 mM DTT, 5% glycerol, and 0.03%
Tween 20) and the protein flow-through was collected. NaCl was added to
this protein fraction up to a 50 mM final concentration before mixing with
500 
 
m
 
l of TALON™ metal affinity resin (Clontech) equilibrated with
buffer C (20 mM sodium phosphate, pH 8.0, 50 mM NaCl, 5% glycerol,
and 0.5 mM DTT) for 30 min. The suspension was deposited on an empty
column and the flow-through was discarded. The resin was rinsed with
20 ml of buffer C and VASP was eluted with buffer D (20 mM sodium
phosphate, pH 7.0, 50 mM NaCl, 0.5 mM DTT, 5% glycerol, 100 mM imi-
dazole, pH 7.0, 100 mM EDTA, pH 7.0, and protease inhibitors). VASP
was dialyzed against VASP buffer (20 mM Hepes-NaOH, pH 7.8, 30 mM
NaCl, 1 mM DTT, and 5% glycerol). The composition of VASP buffer
was worked out to optimize the solubility of VASP. After centrifugation
at 400,000 
 
g
 
 at 4
 
8
 
C for 30 min, the protein was stored at 
 
2
 
80
 
8
 
C at a con-
centration of 10–20 
 
m
 
M. The concentration of VASP was determined by
the Bradford protein assay (Bio-Rad) using BSA as a standard. 2–3 mg of
pure VASP was thus obtained from a 250-ml culture. Electrophoretic pat-
terns of the eukaryotic recombinant protein showed two bands migrating
as 54- and 50-kD polypeptides, representing 40 and 60% of the material,
respectively. Both polypeptides were recognized by the anti-VASP M4
antibody and the anti-Xpress mAb (Invitrogen). After treatment with
PKA catalytic subunit, the material migrated as a single 54-kD polypep-
tide, and after treatment with alkaline phosphatase, as 50 kD. Therefore,
the two bands of the eukaryotic recombinant VASP represent the serine
157–phosphorylated VASP (49.5 kD) and the unphosphorylated VASP
(46 kD) usually found in platelets (Butt et al., 1994), to which the 4-kD fu-
sion peptide has been added.
 
Extracts
 
Platelet extracts were prepared from outdated unstimulated human plate-
lets essentially as described (Laurent and Carlier, 1998). The platelet ly-
sate obtained by sonication in buffer A containing 10 mM Tris-Cl
 
2
 
, pH
7.5, 10 mM EGTA, 2 mM MgCl
 
2
 
, and antiproteases (10 
 
m
 
g/ml of leupep-
tin, pepstatin, and chymostatin, and 1 mM PMSF) was centrifuged at
100,000 
 
g
 
 for 45 min at 4
 
8
 
C. The supernatant was supplemented with 2 mM
ATP, 2 mM DTT, and 150 mM sucrose, rapidly frozen on liquid nitrogen,
and stored at –80
 
8
 
C.
Mouse brain extracts were prepared by homogenization of brains from
freshly decapitated mice in two volumes of ice-cold buffer A, using a 0.5 ml
glass/Teflon potter (20 strokes), followed by sonication (3 
 
3
 
 15 s, low
power) and centrifugation at 100,000 
 
g
 
 for 1 h at 4
 
8
 
C. The supernatant was
frozen on liquid nitrogen and stored at 
 
2
 
80
 
8
 
C.
 
Bacterial Strains
 
L
 
.
 
 monocytogenes
 
 strain Lut12 (pactA3) overexpressing ActA (Kocks
et al., 1992; Marchand et al., 1995) was used. Bacteria were grown over-
night at 37
 
8
 
C in brain/heart infusion medium in the presence of 7 
 
m
 
g/ml
chloramphenicol and 5 
 
m
 
g/ml erythromycin. The culture was then brought
into fresh medium (5 ml) at an optical density of 0.3 at 560 nm, and grown
to stationary phase (1.5–2.0 OD units at 560 nm). After addition of 30%
glycerol to the medium, bacteria were frozen in 100-
 
m
 
l aliquots on liquid
nitrogen and stored at 
 
2
 
80
 
8
 
C.
 
In Vitro Motility Assays of Listeria
 
Frozen bacteria were thawed, centrifuged, and resuspended at 6 
 
3
 
 10
 
9
 
bacteria/ml in B buffer (10 mM Hepes, pH 7.7, 0.1 M KCl, 1 mM MgCl
 
2
 
,
0.1 mM CaCl
 
2
 
, and 50 mM sucrose). The motility assay solution (16 
 
m
 
l)
was prepared at room temperature by mixing 4 
 
m
 
l of cytoplasmic brain or
platelet extract and 12 
 
m
 
l additional ingredients (from concentrated stock
solutions) coming up to the following final concentrations: 0.38% methyl-
cellulose, 5 
 
m
 
M F-actin (added to platelet extracts only), 6 mM DTT, 2 mM
ATP, 4 mM MgCl
 
2
 
, 1.5 
 
3
 
 10
 
2
 
3
 
 % DABCO as an oxygen scavenger, 1 
 
m
 
M
rhodamine-actin, and 2 
 
3
 
 10
 
8
 
 bacteria/ml. After thorough mixing, 2.5 
 
m
 
l of
the suspension was squashed between a BSA-coated slide and a 20 
 
3
 
20-mm coverslip. The depth of the chamber was 6 
 
m
 
m. The sample was
sealed with VALAP (Vaseline/lanosterol/paraffin, 1:1:1). Movement of 
 
L
 
.
 
monocytogenes
 
 was observed at room temperature 10 min after prepara-
tion of the sample in a Zeiss III RS microscope equipped with a Lhesa
LHL4036 silicon-intensified camera. Bacteria were observed both in
phase-contrast and in fluorescence. Movement was recorded in real time
or time lapse using a Panasonic video recorder. Rates of movement were
measured using a Hamamatsu image analyzer. 6–15 measurements were
made on different bacteria for each sample. Average rates were derived
from the distances moved over a period of 1 min. Standard deviations
were calculated using the statistical tools of Kaleidagraph software. Many
bacteria (
 
.
 
200) were counted to derive the percentage of motile bacteria
in a given experiment. All results shown have been obtained reproducibly
in at least four independent experiments, and data shown in figures are
typical data.
 
VASP, Evl, and Profilin Depletion in Platelet or
Brain Extracts
 
VASP was immunodepleted from platelet extracts using 4.5-
 
m
 
m-diameter
goat anti–mouse IgG-coated magnetic Dynabeads (Dynal). The binding
capacity was 0.3–0.4 
 
m
 
g antibodies per 10
 
7
 
 beads. 2 
 
3
 
 10
 
8
 
 Dynabeads were
suspended and extensively washed in PBS containing 1 mg/ml BSA, then
incubated with a sixfold excess of monoclonal anti-VASP antibody (mAb
245) which was shown, by epitope mapping, to recognize the proline-rich
central region of VASP. The concentration of the antibody was 5.8 mg/ml. 
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Incubation was carried out for 30 min at room temperature, with rotary
stirring. After extensive washing of the beads with PBS containing 0.1%
BSA, the beads were split in two batches for two consecutive cycles of de-
pletion. In the first cycle 10
 
8
 
 anti-VASP–coated beads were incubated
with 20 
 
m
 
l of platelet extract at 48C for 90 min with rotary stirring. The su-
pernatant from the first cycle of depletion was submitted to a second cycle
using the second batch of Dynabeads. Mock-depleted extracts were ob-
tained by identical treatment of extracts by uncoated Dynabeads. The ex-
tent of VASP deletion was quantitated by immunoblotting using a poly-
clonal anti-VASP antibody.
Evl immunodepletion from mouse brain extracts was performed as fol-
lows. 4 3 108 Dynabeads were coated (to saturation) with monoclonal
anti-Evl for 30 min at room temperature and split into four batches. The
supernatants were removed. Four consecutive cycles of depletion of 20 ml
of brain extracts were performed at 48C for 60 min. Mock-depleted ex-
tracts were treated identically in parallel using uncoated Dynabeads.
Profilin was depleted from platelet extracts by poly-L-proline chroma-
tography. 50 ml of extract was chromatographed through 50-ml poly-L-pro-
line-agarose columns that had been first equilibrated in 10 mM Tris-Cl2,
pH 7.5 buffer, then rapidly centrifuged in a bench Eppendorf centrifuge to
remove interstitial buffer. The extract-loaded columns were centrifuged at
48C for 1 min. The profilin-depleted flow-through was recovered. This op-
eration was repeated once to obtain .98% depletion of profilin (see
Marchand et al., 1995), as checked by immunoblotting. The extract thus
obtained appeared to be partially depleted (z60%) in VASP. After a
third chromatography step on poly-L-proline-agarose, VASP was no
longer detected by immunoblotting. Since the lowest detectable amount
of VASP is 20 nM and the total amount of VASP in platelet extracts is
0.7 mM (see Results), we consider that the extent of depletion of VASP
was at least 97%. This last result also demonstrates that VASP binds to
the poly-L-proline column.
Polymerization Measurements
VASP-induced polymerization of MgATP-G-actin was monitored at 208C
by the increase in fluorescence of pyrenyl-labeled actin using a Spex Fluo-
rolog 2 spectrophotometer. The excitation wavelength was 366 nm, and
the emission wavelength was 407 nm. The excitation and emission slits
were maintained small enough so that the fluorescence measured at 407 nm
was not contaminated by scattered light due to bundle formation. Alter-
natively, the polymerization process was monitored by turbidimetry using
a Cary 1 spectrophotometer, at a wavelength of 310 nm and using 120-ml
cuvettes thermostatted at 208C. At the end of the polymerization process,
samples were centrifuged at 400,000 g for 20 min at 208C. The amounts of
sedimented F-actin and unassembled actin were determined by SDS-
PAGE of the resuspended pellets and of the supernatants. Gels were ei-
ther Coomassie blue stained or silver stained according to Morrissey
(1981). The gel patterns were scanned using an Arcus (Agfa) scanner and
analyzed using the Image Analysis NIH software.
Electron Microscopy
Samples of preincubated MgATP-G-actin (1 mM) and VASP (1–2 mM)
were deposited on air glow-discharged carbon-coated grids, negatively
stained with 2% uranyl acetate, and observed in a Philips CM12 electron
microscope. Electron micrographs were taken at a 35,000-fold magnifica-
tion.
Results
VASP Is Required for Listeria Movement in Platelet 
Extracts: Role of the Interaction of the EVH1 Domain 
with ActA
VASP was immunodepleted from platelet extracts using
magnetic Dynabeads coated with an antibody directed
against the proline-rich region of VASP. Listeria did not
move in VASP-depleted extracts, whereas the mock-
depleted extracts fully supported motility as efficiently as the
untreated extracts. Specifically, the fraction of motile bac-
teria (30–40%) was the same in the untreated and mock-
depleted extracts. Although no actin tails were assembled
around Listeria after depletion of VASP, actin actively po-
lymerized at the surface of the bacteria into large, loosely
organized, veil-like actin meshworks, as illustrated in Fig.
1. Add-back of the bacterial recombinant VASP protein at
concentrations as low as 0.25 mM restored the movement
of bacteria. The optimum concentration of VASP was 0.5–1
mM. Data showing the extent of VASP depletion and the
dependence of the speed of bacteria on VASP concentra-
tion are displayed in Fig. 2. The speed of propulsion was
not affected by addition of 1 mM VASP to the undepleted
extracts. Upon addition of larger amounts of VASP (5 mM),
bright actin bundles of rhodamine-F-actin were observed
in platelet extracts and inhibition of movement started to
be observed. Using recombinant VASP as a standard, the
concentration of VASP in platelet extracts was deter-
mined to be 0.7 6 0.2 mM by immunoblotting (Fig. 2),
which corresponds to z4  6 1 mM in the platelet cyto-
plasm, assuming a sixfold dilution of the cytoplasm in the
extracts (Carlier et al., 1997). The successful reconstitution
Figure 1. VASP is essential for actin-based motility of Listeria in
platelet extracts. Actin structures formed by L. monocytogenes
in: a and a9, mock-depleted platelet extract; b and b9, VASP-
depleted extract (two cycles of depletion on anti-VASP–coated
Dynabeads); c and c9, VASP-depleted extract supplemented with
1 mM bacterial recombinant VASP; d and d9, VASP-depleted ex-
tract supplemented with 0.9 mM eukaryotic recombinant VASP.
(a–d) Phase-contrast; (a9–d9) corresponding rhodamine-actin flu-
orescence. Bar, 5 mm.Laurent et al. VASP and Actin-based Motility of Listeria 1249
of  Listeria movement was observed with unphosphory-
lated bacterial VASP as well as with the eukaryotic recom-
binant VASP in an identical range of concentrations (Fig.
1, d and d9).
VASP has been shown to interact with ActA via its
NH2-terminal EVH1 domain. To verify the implication of
this interaction in Listeria movement, extracts were sup-
plemented with 2.5 mM GST-EVH1 fusion proteins of
VASP, Mena, and Evl which share sequence homology
(Table I). No inhibition of Listeria movement was ob-
served when bacteria were added to the extracts supple-
mented with GST-EVH1. On the other hand, when bacte-
ria were separately preincubated with GST-EVH1 proteins
for 20 min before being added to the extracts, so that the fi-
nal concentration of GST-EVH1 was again 2.5 mM, bacteria
initially did not move and appeared surrounded by disor-
ganized actin clouds. After 30 min of incubation in the ex-
tracts, bacteria slowly resumed normal movement and
comet tails eventually were seen. The rate of propulsion
eventually decreased at late times, most likely due to ATP
depletion. These data indicate that the EVH1 domain of
VASP, Mena, and Evl is in slow association–dissociation
equilibrium with the poly-L-proline region of ActA. In ad-
dition, the fact that endogenous VASP at 0.7 mM eventually
displaces ActA-bound EVH1 when isolated EVH1 is
present at 2.5 mM indicates that the affinity of VASP in
the macromolecular assembly is much higher than the af-
finity of EVH1 for ActA, suggesting that VASP interacts
either with other regions of ActA or with partners other
than ActA at the surface of Listeria, and these interactions
strengthen its overall affinity for ActA. To discriminate
between the above two possibilities, the effect of the GST-
(proline-rich region of ActA) fusion protein on Listeria
motility was tested. Addition of the fusion protein at con-
centrations as low as 0.8 mM (a concentration equimolar to
endogenous VASP) completely blocked the movement of
Listeria, and reduced by twofold the percentage of bacte-
ria able to initiate assembly of actin at the bacterium sur-
face. This result demonstrates that the proline-rich region
of ActA binds VASP with high affinity, and the VASP-
Pro(ActA) complex cannot further interact with ActA.
Accordingly, the movement of Listeria was not reconsti-
tuted in VASP-depleted extracts when bacteria were pre-
incubated with GST-EVH1 proteins.
In conclusion, VASP binds ActA via interaction of the
EVH1 domain of VASP with the proline-rich region of
ActA, and this interaction is necessary but not sufficient
for the activity of VASP in motility. Hence the interaction
of VASP with other ligands increases the overall affinity
of VASP for the macromolecular assembly responsible for
motility, and is necessary for actin-based motility of Listeria.
Overall, the sequence of the Evl protein is most similar
to VASP, in particular the EVH1 domains of VASP and
Evl present 61% identity. The Evl recombinant protein
was found able to restore actin-based motility of Listeria
in VASP-depleted platelet extracts (Fig. 2 c). Interest-
ingly, the rate of movement was lower upon addition of
Evl to the VASP-depleted extracts than upon addition of
VASP. Since the EVH1 domains of VASP and Evl are
equally able to bind ActA, this difference may be due to
differences in the interaction of VASP and Evl with an-
other partner.
Movement of Listeria in Brain Extracts: Mena and Evl 
Can Be Replaced by VASP
The role of Mena and Evl in Listeria movement was
addressed using Mena knockout (2/2) animals. Mouse
brain extracts prepared as described in Materials and
Methods were assayed for Listeria movement. Images of
Listeria undergoing actin-based motility in brain extracts
are displayed in Fig. 3. The rate of propulsion was 5–10-
fold slower than in platelet extracts (0.15–0.3 mm/min).
Because of these very slow rates, the standard deviations
in rate measurements were as high as 30–40%. For that
reason, the motility data in brain extracts were not reliably
expressed in terms of rates and the statistics were prefera-
bly expressed in terms of percentages of motile bacteria
and of bacteria surrounded by actin “clouds” but not mov-
Figure 2. Immunodepletion of VASP from platelet extracts and
Listeria movement in VASP-depleted extracts supplemented
with recombinant VASP or Evl. (a) Quantitation of VASP in
platelet extracts. 0.5 (lane 1), 1 (lane 2), and 2 pmol (lane 3) of re-
combinant VASP and 0.66 (lane 4), 1.33 (lane 5), and 2.66 ml
(lane 6) of platelet extract were electrophoresed and immuno-
blotted using anti-VASP (M4 polyclonal antibody). Comparison
of the densitometric patterns of the standards and of platelet
VASP using the NIH Image analysis software led to an estimate
of 0.7 mM VASP in the extracts. (b) Analysis of the immunode-
pletion of VASP from platelet extracts. Lane 1, whole extract;
lane 2, mock-depleted extract; lane 3, VASP-depleted extract
(two cycles of depletion using Dynabeads); lane 4, Dynabead-
bound VASP after the first cycle of depletion; lane 5, Dynabead-
bound VASP after the second cycle of depletion; and lane 6,
control beads (not coated with anti-VASP) used for the mock de-
pletion. The Western blot was revealed using M4 polyclonal anti-
VASP. (c) Mean rates of movement of Listeria in VASP-depleted
extracts and in depleted extracts supplemented with VASP or
Evl recombinant proteins. 10–15 rate measurements were per-
formed for each sample. At least three independent experiments
were carried out.The Journal of Cell Biology, Volume 144, 1999 1250
ing. In contrast to the observation made on platelet ex-
tracts, the rate of movement did not increase, but decreased,
upon addition of exogenous F-actin to the motility assay
mixture. Therefore, motility assays were performed with-
out additional F-actin. Preliminary experiments showed
that the percentages of motile bacteria (all motile bacteria
formed comet tails) and of bacteria surrounded by actin
clouds were identical in brain extracts from wild-type ani-
mals and from knockout (both heterozygous 2/1 and
homozygous 2/2) animals, leading to the tentative con-
clusion that the Evl protein, homologous to Mena, is suf-
ficient to support movement in the absence of Mena.
Quantitative immunoblotting assays (Fig. 4 a) show that
the 48-kD Evl protein is present at a concentration of 0.7
mM in brain extracts. Identical amounts of Evl were found
in brain extracts from wild-type and Mena (2/2) animals
(data not shown). Immunodepletion of Evl in wild-type
or heterozygous Mena (1/2) extracts did not affect the
movement of Listeria (Fig. 4 b). The rates of movement
were the same as in the undepleted controls (within the
30% standard deviation). In contrast, partial immunode-
pletion of Evl in Mena (2/2) extracts (not shown) caused
an appreciable inhibition of movement and of the forma-
tion of regular actin tails. A large proportion of coiled, dis-
organized actin comets was then seen around the bacteria.
Complete inhibition of movement and a total absence of
actin tails were obtained upon depletion of Evl in Mena
(2/2) extracts (Fig. 4, a and c). Since the lowest detect-
able amount of Evl is 50 nM (see below), the extent of de-
pletion was at least 93%. However, polymerization of ac-
tin in unorganized meshworks was still observed around
the bacteria. Hence Evl, like VASP, was not required for
actin polymerization per se. Add-back of 1.1 mM pure re-
combinant Evl to Evl-depleted extracts of Mena (2/2)
mice restored Listeria motility. Motility was equally well
restored by addition of 0.6 mM bacterial recombinant
VASP. The percentage of motile bacteria in the add-back
of Evl or VASP was twice lower than in the mock-depleted
control. Despite this lower performance, which was less
quantitatively observed in other independent experiments,
the difference between the Evl-depleted samples, which
are totally immotile, and the (depleted 1 add-back of Evl
or VASP) sample was reproducible and testifies for the
role of Evl or VASP in movement. In conclusion, the re-
quirements for Listeria motility in Evl-depleted brain ex-
tracts of Mena (2/2) mice were identical to the ones ob-
served in VASP-depleted platelet extracts. Addition of a
twice larger amount of VASP led to the massive formation
of large bundles of rhodamine-actin in the brain extract,
and subsequent inhibition of the formation of actin tails.
These results show that Mena, Evl, and VASP play in-
terchangeable roles in Listeria movement and most likely
bind to the same molecular targets in this function.
Profilin Is Not Required for Listeria Motility, but 
Increases Bacterial Speed
Depletion of profilin in platelet extracts by poly-L-proline
chromatography did not abolish the movement of Listeria.
In the total absence of profilin, and 60% of endogenous
VASP, obtained by two consecutive poly-L-proline chro-
matography steps of the platelet extracts (see Materials
and Methods), Listeria moved at a 30% lower speed than
in the mock-depleted extract. Double depletion of both
VASP and profilin by three consecutive poly-L-proline af-
finity columns (see Materials and Methods) caused the ar-
rest of movement. Add-back of profilin alone did not
restore movement. Movement was restored in the double-
depleted extracts by adding back VASP alone (60% of the
bacterial speed observed in the mock-depleted extract).
Further addition of profilin increased the rate of move-
Table I. Movement of Listeria monocytogenes in Platelet 
Extracts: Role of the EVH1 Domain of Proteins of the
Ena/VASP Family
Experiment Conditions Rate of movement
% of bacteria
surrounded by
actin clouds
mm/min
1 Control 4.5 6 0.6 (12)
0 at t 5 10 min
1 2.5 mM GST-EVH1 (VASP) 3.9 6 0.7 (4) at
t 5 30 min
1.6 6 0.5 (4) at
t 5 120 min
1 2.5 mM GST-EVH1 (Mena) 0 at t 5 10 min
1 2.5 mM GST-EVH1 (Evl) 0 at t 5 10 min
2 Control 5.4 6 0.4 (11) 27 (223)
1 0.8 mM GST-Pro(ActA) 0 15 (324)
1 1.6 mM GST-Pro(ActA) 0 16 (121)
Numbers in parentheses indicate the number of measurements from which the average
value was calculated. The control was performed by adding to the extract a volume of
PBS equal to the volume of reagent added to the sample.
Figure 3. Movement of L. monocytogenes in mouse brain ex-
tracts from wild-type and Mena (2/2) animals. Typical actin tails
formed in wild-type (a and a9) and in Mena (2/2) (b and b9)
mouse brain extracts. (a and b) Phase-contrast; (a9 and b9)
rhodamine-actin fluorescence. c shows a time-lapse illustration of
the movement. Bar, 5 mm.Laurent et al. VASP and Actin-based Motility of Listeria 1251
ment to 80% of the value observed in the mock-depleted
extract (Fig. 5). These results demonstrate that profilin is
not required for Listeria motility, in agreement with previ-
ous results obtained in Xenopus egg extracts (Marchand et
al., 1995), and that VASP can support Listeria movement
independent of profilin. The profilin-induced 30% in-
crease in speed, an indication that profilin increases the ef-
ficiency of motility, may be due to profilin’s known func-
tion in actin dynamics (see Discussion), or to its ability to
interact directly with the (GP5) sequence, repeated to dif-
ferent extents in VASP/Mena/Evl proteins. To further ex-
amine the latter possibility, the effect of the (GP5)3 pep-
tide on Listeria movement in platelet extracts was assayed.
Addition of the peptide at 1 mM slowed down the move-
ment to an extent that varied widely from 20 to 60% in a
large number of different experiments. The result con-
trasts with the very efficient inhibition of movement which
was observed when micromolar amounts of this peptide
were injected in infected cells (Kang et al., 1997). A similar
weak and low-affinity effect was obtained upon addition
of poly-L-proline (Sigma Chemical Co.) at concentrations
(5–10 mM proline) comparable to those of (GP5)3. Since
VASP itself binds to poly-L-proline (see Materials and
Methods), we cannot eliminate the possibility that the
(GP5)3 peptide and poly-L-proline inhibit movement by
displacing VASP from the proline-rich region of ActA as
weak competitors. The low-affinity inhibitory effect of the
(GP5)3 peptide on Listeria movement contrasts with the
very efficient inhibition observed by addition of micromo-
lar amounts of EVH1 or Pro-ActA fusion proteins. In
summary, no evidence for a functional role of the central
region of VASP in Listeria movement can be drawn from
the effect of this peptide in the present in vitro assay.
Possible Involvement of Platelet Evl and of Brain VASP 
in Listeria Movement
Many tissues contain two or all three proteins (Mena,
VASP, Evl) of the Ena/VASP family (Lanier et al., 1999).
Since these proteins play interchangeable roles in Listeria
movement, one can legitimately wonder why the VASP
present in Evl-depleted Mena (2/2) mouse brain extracts
or the Evl protein present in VASP-depleted platelet ex-
tracts does not support Listeria movement. One possible
explanation could be that the amounts of soluble Evl in
platelets and of VASP in brain are so low that after deple-
tion of the major variant (VASP in platelets, Evl in Mena
(2/2) brains), the concentration of the less abundant pro-
tein is below the threshold at which movement can be ob-
served.
To test this possibility, the amounts of Evl present in
platelet extracts and of VASP in brain extracts were evalu-
ated by quantitative immunoblotting. Fig. 6 shows that
when the highest possible volumes of extracts (obtained
with low ionic strength buffer, in the absence of detergent)
were loaded on the gel, VASP could not be detected in
brain extracts, nor Evl in platelet extracts. Considering the
lower limits of immunodetection of these proteins, the re-
sult indicates that the concentration of soluble Evl in
platelet extract is lower than 50 nM, and the concentration
of soluble VASP in brain extracts is lower than 20 nM.
These amounts appear too low to support movement of
Listeria. Hence, our results suggest that the fraction of sol-
uble Mena and Evl is larger than the fraction of soluble
VASP in brain under the lysis conditions used to prepare
these extracts. Experiments using higher ionic strength/
detergent lysis indicate that pools of VASP in brain and
Evl in platelets exist which are not solubilized by these
conditions (Lanier et al., 1999; Gertler, F.B., unpublished
observations).
VASP Interacts with Actin via Its EVH2 Domain: 
Implication in Listeria Movement
The above results demonstrate that VASP, Evl, and Mena
play interchangeable roles in actin-based motility of Liste-
Figure 4. Evl is essential for actin-based motility of Listeria in
mouse brain extracts. (a) Western blot analysis of Evl depletion
from Mena (2/2) mouse brain extracts. Lane 1, 15 pmol of re-
combinant Evl; lane 2, 10 ml mock-depleted extract; lane 3, 10 ml
Evl-depleted extract; lane 4, Dynabead-bound Evl after the first
cycle of depletion; and lane 5, control Dynabeads used for the
mock depletion. The blot was revealed using an anti-Evl mAb.
(b) Effect of Evl depletion on Listeria movement in wild-type
brain extracts. The percentages of motile bacteria, defined as:
(number of motile bacteria/number of total bacteria) 3 100 (dark
gray bars), and of immotile bacteria that were surrounded by ac-
tin clouds, defined as: (number of nonmotile bacteria surrounded
by actin clouds/number of total bacteria) 3 100 (light gray bars),
were determined under each condition. 271 6 24 bacteria were
counted for each measurement. Motile bacteria moved at rates
that fell in the range of 0.16 6 0.06 mm/min in all samples. (c) Ef-
fect of Evl depletion on Listeria movement in Mena (2/2)
mouse brain extracts. Data are represented as in b. 282 6 49 bac-
teria were counted for each measurement.The Journal of Cell Biology, Volume 144, 1999 1252
ria. They bind ActA via their EVH1 domain and their
common function implies that they interact with another
unknown common ligand. Like EVH1, the EVH2 domain
is well conserved among the Ena/VASP proteins. Trunca-
tion of this region abolishes the localization of VASP to
focal contacts (Haffner et al., 1995), indicating that this re-
gion, like EVH1, may play a role in the targeting of VASP,
though the direct contacts with ActA or zyxin are likely to
be mediated only through the EVH1 domain. Since VASP
appears necessary, in Listeria motility, to transform actin
polymerization in “clouds” into an organized actin struc-
ture supporting active movement, we assayed the inter-
action of recombinant VASP with actin by in vitro assays
combining pyrenyl-actin fluorescence, light scattering,
electron microscopy, and sedimentation measurements.
Such in vitro assays allow a quantitative comparison of the
nonphosphorylated bacterial VASP recombinant protein
with the partially phosphorylated eukaryotic recombinant
VASP. Both recombinant proteins induced the polymer-
ization of G-actin at low ionic strength, suggesting that
VASP binds polymerized actin preferentially. The effect
of VASP was very similar to the myosin-subfragment-
1–induced assembly of G-actin (Miller et al., 1988), except
that it was ATP insensitive. The polymerization process
of MgATP-G-actin induced by eukaryotic recombinant
VASP was monitored by the increase in fluorescence of
pyrenyl-labeled actin (Fig. 7 a) and by the increase in light
scattering or in turbidity at 310 nm (Fig. 7 b). Very similar,
if not strictly kinetically identical data were obtained with
the bacterial recombinant protein (data not shown). While
the extent of pyrenyl fluorescence and the shape of the flu-
orescence emission spectrum were compatible with the
formation of F-actin, the large increase in turbidity indi-
cated that particles much larger than actin filaments were
assembled from G-actin in the presence of VASP. The ex-
tent of fluorescence change varied with the concentration
of VASP as a high-affinity titration curve (Fig. 7 a, inset),
indicating that 1 mol of actin was assembled per mole of
VASP monomer added, which was confirmed by sedimen-
tation assays (not shown, but identical to data shown in
Fig. 8 b). In contrast, the extent of turbidity change did not
display a saturation behavior, because the thickness of the
bundles increases with protein concentration and with
time, resulting in a nonlinear concentration and time de-
pendence of the turbidity. Electron microscope observa-
tion of negatively stained specimens (Fig. 7 c) showed that
thick F-actin bundles were formed with bacterial and eu-
karyotic recombinant VASPs. The formation of bundles is
fully consistent with the turbidity data. VASP-induced po-
lymerization of G-actin was observed even at submicro-
molar concentrations of VASP and actin, consistent with
the high affinity of VASP for F-actin at low ionic strength
displayed in Fig. 7 a, inset. Polymerization was much more
efficient from Mg-actin than from Ca-actin. The induction
of actin assembly in filament bundles by VASP was fa-
vored in low ionic strength buffers (,20 mM KCl) and was
slowed down upon increasing the ionic strength (Fig. 7 a,
curves d and f; Fig. 7 b, curves d, i, and j). The formation
and ionic strength dependence of F-actin bundles upon ad-
dition of VASP are both consistent with the change in
charge of filaments after VASP binding and the existence
of electrostatic forces between filaments in the bundles
(Tang and Janmey, 1996; Tang et al., 1997). To examine
Figure 5. Profilin is not essential for
actin-based motility of Listeria in
platelet extracts. The mean rate of
movement of Listeria was measured in
mock-depleted extracts, profilin-depleted
extracts, profilin 1 VASP double-
depleted extracts, supplemented with
the indicated amounts of recombinant
VASP or purified bovine profilin.
Mean rate values result from the aver-
age of 10 measurements.
Figure 6. Immunodetection of VASP in mouse brain extracts
and of Evl in platelet extracts. (a) Platelet extract (1, 2, and 4 ml,
corresponding to 0.7, 1.4, and 2.1 pmol of VASP, in lanes 1, 2, and
3, respectively), Mena (2/2) mouse brain extracts (10 and 20 ml in
lanes 4 and 5), and wild-type mouse brain extracts (10 and 20 ml
in lanes 6 and 7) were analyzed by immunoblotting using poly-
clonal M4 anti-VASP antibody. Assuming that the limit of detec-
tion is 0.4 pmol, the data indicate that the maximum concentra-
tion of VASP in brain extracts is 20 nM, a concentration too low
to support Listeria movement. (b) Wild-type mouse brain ex-
tracts (5, 10, and 20 ml corresponding to 3.5, 7, and 14 pmol of Evl
in lanes 1, 2, and 3, respectively) and 10, 20, and 40 ml platelet ex-
tracts (lanes 4, 5, and 6, respectively) were analyzed by immuno-
blotting using a polyclonal anti-Evl antibody. Assuming that the
lower limit of detection is 2 pmol Evl, the data indicate that the
maximum concentration of Evl in platelets is 50 nM, which is too
low to support motility of Listeria.Laurent et al. VASP and Actin-based Motility of Listeria 1253
which region of VASP is involved in actin binding, the
effect of the EVH2 domain, which contains the highly
charged COOH-terminal region of VASP, was investi-
gated. The GST-EVH2 fusion protein of VASP induced
F-actin assembly like VASP, except that no bundles were
formed (compare Fig. 7, a and b, curve g). The absence of
bundles when EVH2 was bound to F-actin indicates that
the overall charge of EVH2-F-actin is different from that
of VASP-F-actin. Competition between VASP and GST-
EVH2 was observed (Fig. 7 b, compare curves d and h).
The interaction of VASP with F-actin was then exam-
ined in vitro as follows. Preliminary sedimentation assays
first showed that both bacterial and eukaryotic recombi-
nant VASP cosedimented with F-actin (1–5 mM) in a 1:1
molar ratio of monomeric VASP per F-actin subunit, con-
firming the conclusions of the experiments of induction of
actin assembly. The fluorescence of pyrenyl-labeled F-actin
was not affected by the binding of VASP. Fig. 8 a shows
that in a low ionic strength buffer (MgATP-actin, 15 mM
NaCl, 0.1 mM MgCl2 added to G buffer), addition of 1 mM
VASP shifted the critical concentration for F-actin assem-
bly from 0.2 to 0.1 mM, indicating that VASP increased the
stability of F-actin, i.e., bound F-actin preferentially. The
affinity of VASP for F-actin under physiological condi-
tions (0.1 M KCl, 1 mM MgCl2) was estimated using a sed-
imentation assay. The assays were performed using stan-
Figure 7. VASP induces polymerization of G-actin into F-actin bundles. (a) Pyrenyl-actin fluorescence measurements. 1 mM pyrenyl-
labeled MgATP-G-actin was supplemented, at time indicated by the vertical arrow, with eukaryotic recombinant VASP at the following
concentrations (mM): a, 0; b, 0.25; c, 0.5; d, 1; e, 2; f, 1 mM VASP 1 0.1 M KCl; g, 0 VASP, 2 mM GST-EVH2. The fluorescence of 1 mM
pyrenyl-G-actin is equal to 1 by convention. The horizontal arrow indicates the fluorescence measured for 1 mM F-actin polymerized in
standard F buffer (0.1 M KCl, 1 mM MgCl2 added to G buffer). (Inset) Extent of fluorescence change at the end of the polymerization
process of 0.7 mM MgATP-G-actin induced by VASP at the indicated concentrations. Fluorescence was measured 1 h after the prepara-
tion of the samples. Final conditions were: 5 mM Tris-Cl2, pH 7.5, 0.2 mM ATP, 0.1 mM CaCl2, 1 mM DTT, 0.2 mM EGTA, 50 mM
MgCl2, 2 mM Hepes, 15 mM NaCl, 1% glycerol, 208C. (b) Turbidity measurements at 310 nm. 1 mM MgATP-G-actin (same actin solu-
tion as in a) was supplemented, at time 0, with eukaryotic recombinant VASP at the following concentrations (mM): a, 0; b, 0.29; c, 0.58;
d, 1.16; e, 1.74; f, 2.34; g, 0 VASP, 2 mM GST-EVH2; h, 1.16 mM VASP 1 2 mM GST-EVH2; i, 1.16 mM VASP 1 0.05 M KCl; j, 1.16
mM VASP 1 0.1 M KCl; k, no actin, 1.16 mM VASP. Ionic conditions were as in a. Temperature was 208C. Optical path length 5 1 cm.
(c) Actin bundles assembled from Mg-actin in the presence of VASP. Samples of MgATP-G-actin (1 mM) preincubated for 10 min with
1 mM VASP were negatively stained and observed in the electron microscope. (Top) Bacterial recombinant VASP. (Bottom) Eukary-
otic recombinant VASP.The Journal of Cell Biology, Volume 144, 1999 1254
dard F-ADP-actin and F-ADP-BeF3-actin,  which mimics
the F-ADP-Pi state of F-actin, in parallel samples. The ra-
tionale for this experiment was to determine whether
VASP, in being bound to ActA and to the barbed ends of
growing filaments, which have F-ADP-Pi terminal sub-
units, would show a functionally relevant preference for
either one of the F-ADP or F-ADP-Pi conformations of
F-actin. No difference was observed in the binding of
bacterial and eukaryotic recombinant VASPs to F-ADP
and F-ADP-Pi (data not shown). On the other hand, the
two eukaryotic VASP polypeptides corresponding to the
serine 157–dephosphorylated form (46 kD, which we will
call dephospho-VASP) and the serine 157–phosphory-
lated form (50 kD, which we will call phospho-VASP)
bound F-actin with different affinities. Typical data dis-
played in Fig. 8 b show that when 0.5 mM eukaryotic
VASP was mixed with 1 mM F-actin, phospho-VASP,
which represented z30% of the material, was practically
all bound to F-actin, consistent with an equilibrium disso-
ciation constant lower than 0.05 mM, while 50% of de-
phospho-VASP was bound to F-actin, consistent with an
equilibrium dissociation constant of z1 mM. The values of
the equilibrium dissociation constants for binding of de-
phospho-VASP and phospho-VASP to F-actin, KX, and
KY, respectively, were derived from the quantitative anal-
ysis of the scanned gel patterns using a model in which the
two forms of VASP bind to the same site on F-actin. The
following equations were used:
KX F [] X0 []X []1 – ¤ () ¤ =
KY F [] Y0 []Y [] 1 – ¤ () ¤ =
was polymerized under physiological ionic conditions (0.1 M
KCl, 1 mM MgCl2) and mixed at 1 mM with VASP at the indi-
cated concentrations. Samples were centrifuged for 30 min at
400,000  g, 208C. Pellets were resuspended in G buffer at the orig-
inal volume. Pellets (P) and supernatants (S) were submitted to
SDS-PAGE. A, actin alone (1 mM); V, VASP alone (2 mM); *,
50-kD band corresponding to serine 157–phosphorylated VASP;
**, 46-kD band corresponding to serine 157–unphosphorylated
VASP. Data are plotted as bound VASP versus free VASP. The
concentrations of free and F-actin–bound VASPs were derived
from the scanning of the gels (see Materials and Methods). The
curves represent the fit to the data using values of equilibrium
dissociation constants KY 5 22 nM and KX 5 0.8 mM for phos-
pho- and dephospho-VASP, respectively (see text). (c) Sedimen-
tation assay for EVH2 binding to F-actin. F-actin (1 mM) poly-
merized in physiological ionic conditions was incubated with
EVH2 at the following concentrations in mM: 1, 0; 2, 0.25; 3, 0.5;
4, 0.75; 5, 1.0; 6, 1.5; 7, 2; 8, 3; 9, 5; 10, 3 mM EVH2, no actin. Su-
pernatants (S) and pellets (P) of sedimented samples were sub-
mitted to SDS-PAGE. Data are plotted as F-actin bound EVH2
versus free EVH2 as in b. The data are analyzed as in b and the
curves are fit to the data using a value of the equilibrium dissoci-
ation constant of 0.69 6 0.1 mM. (d) Competition between GST-
EVH2 and VASP for binding to F-actin. F-actin (1 mM) polymer-
ized in physiological ionic conditions was incubated with: 1, no
additions; 2, 1 mM eukaryotic recombinant VASP and 4 mM
GST-EVH2; 3, 4 mM GST-EVH2. Samples were sedimented at
400,000 g and supernatants (S) and pellets (P) were submitted to
SDS-PAGE. A, V, and E correspond to 1 mM actin, 1 mM VASP,
and 4 mM GST-EVH2, respectively. Comparison of lanes 3P and
2P shows that EVH2 is displaced from F-actin by VASP.
Figure 8. VASP binds to and stabilizes F-actin in a phosphoryla-
tion-regulated manner. (a) VASP shifts the critical concentration
plots for actin assembly toward a lower value. Critical concentra-
tion plots for polymerization of Mg-actin in the absence (filled
circles) and presence (open circles) of 1 mM eukaryotic recombi-
nant VASP. Pyrenyl-labeled actin was polymerized at a high con-
centration and serially diluted in buffer adjusted to the following
ionic conditions: 5 mM Tris-Cl2, pH 7.5, 0.2 mM ATP, 0.1 mM
CaCl2, 0.2 mM EGTA, 0.1 mM MgCl2, 1 mM DTT, 2 mM Hepes,
15 mM NaCl, and 1% glycerol. (b) Sedimentation assay for the
binding of eukaryotic recombinant VASP to F-actin. Mg-F-actinLaurent et al. VASP and Actin-based Motility of Listeria 1255
with [X0] 5 0.7 [V0] and [Y0] 5 0.3 [V0]. [V0], [X0], and [Y0]
represent the total concentrations of VASP, of dephos-
pho-VASP, and of phospho-VASP, respectively; [X] and
[Y] represent the concentrations of free dephospho- and
free phospho-VASP measured in the supernatants; and [F]
represents the concentration of unliganded F-actin sub-
units, derived from the difference between total F-actin
and the sum of F-actin–bound phospho- and dephospho-
VASP, measured in the pellets.
Values of 0.8 6 0.1 and 0.02 6 0.01 mM were thus found
for KX and KY (Fig. 8 b). In conclusion, phosphorylated
VASP binds F-actin with a 40-fold higher affinity than de-
phosphorylated VASP.
It has been demonstrated that the shift in apparent mo-
lecular mass of VASP from 46 to 50 kD is linked to phos-
phorylation of serine 157 exclusively, while phosphoryla-
tion at other sites (serine 239, threonine 278) does not
affect the electrophoretic migration in denaturing gels
(Waldmann et al., 1987). Accordingly, both the 46-kD and
the 50-kD polypeptides may be partially phosphorylated
on other sites, e.g., serine 239 (Smolenski et al., 1998).
Nonetheless, in its high-affinity binding to actin, the 50-kD
phospho-VASP polypeptide behaves as a homogeneous
population, which suggests that the phosphorylation of
serine 157 is solely responsible for the strong binding to
F-actin. A different, more complex, bimodal behavior
would be displayed in the binding curves if phosphoryla-
tion of serine 239 affected the affinity of VASP for F-actin.
In conclusion, the phosphorylation of serine 157 by the
cAMP-dependent protein kinase regulates the affinity of
VASP for F-actin. Our results showing that VASP binds
F-actin are in qualitative agreement with earlier data using
VASP purified from platelets (Reinhard et al., 1992), but
the binding stoichiometry and the affinity of VASP for
actin were not estimated, and the experiments were not
conducted under conditions appropriate to measure a dif-
ference in affinity between phosphorylated and nonphos-
phorylated VASP.
Finally, cosedimentation assays, displayed in Fig. 8, c
and d, showed that GST-EVH2 bound to F-actin in a 1:1
molar ratio with an equilibrium dissociation constant of
0.7 mM and in competition with VASP. In conclusion, the
interaction of VASP with F-actin is mediated by its EVH2
domain.
To understand the function of the interaction of VASP
with F-actin in motility of Listeria, the effect of the
GST-EVH2 on Listeria movement in platelet extracts was
tested. Addition of 3.5 mM GST-EVH2 to the motility as-
say mix led to the formation of ill-defined actin tails. Upon
addition of 7 mM GST-EVH2, no actin tails were formed
and bacteria did not move. These data, which corroborate
the competition between VASP and EVH2 for binding to
F-actin, indicate that the interaction of VASP with actin,
mediated by the EVH2 domain, is essential in its function
in actin-based motility. The fact that a 10-fold molar ex-
cess of EVH2 over VASP is necessary to inhibit move-
ment, while the affinity of EVH2 and of VASP for F-actin
are identical, is again consistent with the multiple interac-
tion of VASP in the macromolecular assembly responsible
for motility.
V0 [] X0 [] Y0 [] , + = Discussion
The in vitro motility assay of L. monocytogenes in platelet
and brain extracts has been used as a tool to demonstrate
that proteins of the Ena/VASP family are required for ac-
tin-based motility. Since active actin polymerization, but
no movement, is observed around the bacteria after selec-
tive removal of VASP from platelet extracts (or of Mena
and Evl from brain extracts), we conclude that these pro-
teins do not act as actual nucleators of actin assembly, but
as organizers of the actin meshwork for the efficient pro-
duction of propulsive force. This conclusion is in full
agreement with the one derived from genetic studies show-
ing that the deletion of the four proline-rich repeats of
ActA caused a severe inhibition of Listeria movement in
infected cells and in Xenopus egg extracts (Smith et al.,
1996). Although bacteria expressing modified ActA still
induced actin assembly, the number of bacteria moving
(albeit at a fourfold reduced speed) was 10-fold lower than
for wild-type bacteria. A 5.5-fold reduced speed of move-
ment in infected cells was also observed in a second report
(Niebuhr et al., 1997). The quantitative difference be-
tween the observations derived from genetically modified
Listeria and the present in vitro VASP/Mena/Evl deple-
tion studies lies in the fact that in the previous experi-
ments, proteins of the Ena/VASP family were still present
in the medium. Therefore, the possibility cannot be dis-
counted that low-affinity binding of these proteins to
subsites on ActA, undetectable by immunofluorescence,
would be sufficient to elicit slow movement of a few bac-
teria. Interestingly, a motility phenotype similar to the
one obtained upon VASP removal (actin polymerization
around the bacteria, indicating that Arp2/3 was recruited,
but no actin tail formation and no movement) was ob-
served upon deletion of the 117-KKRRK-121 peptide in
the NH2-terminal region of ActA (Lasa et al., 1997). Al-
though VASP was bound to these NH2-terminal deletion
ActA mutants, the phenotype suggests that it may not
have been bound in a functional fashion. In summary,
while the proline repeats of ActA may represent the main
VASP binding subsite, other regions of ActA may also be
involved in VASP function.
VASP, Mena, and Evl appear to play interchangeable
roles in actin-based motility, in different cellular contexts.
Evl can replace VASP in VASP-depleted platelet extracts,
and VASP can replace both Mena and Evl in Mena knock-
out, Evl-depleted brain extracts. This conclusion is in agree-
ment with a recent report (Ahern-Djamali et al., 1998)
showing that, in vivo, human VASP can substitute for the
loss of Ena in the Drosophila embryo. It shows that these
proteins are likely to interact with the same targets in dif-
ferent cells, and that the role of Ena in neural develop-
ment may be, in analogy with the function of VASP in
Listeria movement, to organize the growth of filaments at
the plasma membrane for the correct development of neu-
ral cells. Whether VASP, Ena, Mena, and Evl are similarly
regulated in different tissues is an open question.
Ena/VASP proteins clearly can support Listeria move-
ment independently of profilin, since the simple add-back
of VASP to extracts that have been double-depleted from
VASP and profilin is sufficient to restore movement of
Listeria at a rate which is 75% of the rate observed uponThe Journal of Cell Biology, Volume 144, 1999 1256
add-back of both VASP and profilin. Listeria movement
does not require profilin, however the increase in bacterial
speed provided by profilin is consistent with its function in
filament turnover (Didry et al., 1998). In the presence of
ADF (2 mM in platelet extracts), profilin increases the
turnover of actin filaments, which powers the movement
of Listeria. Whether an additional effect is provided by the
interaction of VASP/Mena with profilin is an issue which
is not elucidated by our work. The engineering of mutated
forms of VASP unable to bind profilin but binding ActA
and F-actin in an unaltered fashion, or of mutated forms of
profilin unable to bind poly-L-proline but interacting with
actin only, in a complex able to participate in barbed
end assembly like unmodified profilin appears required to
clarify this point. In this context, it is noteworthy that a re-
cent report (Suetsugu et al., 1998) studying the role of pro-
filin in N-WASP–elicited filopodia extension in response
to EGF demonstrates that the ability of profilin to interact
directly with actin is required for N-WASP–mediated filo-
podial extension, and that mutations in the proline-rich re-
gion of N-WASP which abolish the binding of profilin to
N-WASP did not impair filopodium extension, although
the length of the microspikes was greatly reduced.
The in vitro motility assay of Listeria provides quantita-
tive estimates of the affinities of the different domains of
the Ena/VASP proteins involved in building the molecular
scaffold responsible for actin assembly and movement.
The recombinant VASP and Evl proteins used in this
work were efficient at submicromolar concentrations. Use
of the GST-EVH1 and GST-(Pro-ActA) fusion proteins
of VASP, Mena, and Evl demonstrates that the EVH1
domain itself binds the ActA proline-rich region in slow
association–dissociation equilibrium, and with an affinity
which, given the very slow dissociation rate, we tentatively
estimate at least in the 107 M21 range. This implies that the
attachment of VASP to ActA is quasi-permanent during
the movement of Listeria.
VASP interacts also with actin via its EVH2 domain.
The isolated EVH2 domain binds F-actin in a 1:1 molar ra-
tio and an affinity of 0.7 mM, identical to the binding stoi-
chiometry and affinity of dephospho-VASP for F-actin.
The fact that EVH2, in displacing VASP from F-actin,
abolishes the movement, demonstrates that the interaction
of VASP with the filaments of the actin tail is essential in
propulsion. In binding its two targets, ActA and actin,
VASP may work as a molecular connector linking the sur-
face of the bacterium to the growing filament via its EVH1
and EVH2 domains. This result is in full agreement with
the strong bonding between the bacterium and the actin
tail measured with optical tweezers (Gerbal, F.B., V. Lau-
rent, A. Ott, P. Chaikin, M.-F. Carlier, and J. Prost, manu-
script in preparation). Our results expand the conclusion
of these mechanical studies in showing that the attach-
ment of the actin tail to the bacterium is required for
movement, a conclusion at variance with the original
Brownian ratchet model (Peskin et al., 1993). One can
imagine that the connection elicited by VASP between
ActA and actin imposes a structural constraint in the ar-
rangement of the elongating barbed ends at the surface of
Listeria, maintaining them attached to the bacterium and
bundled in a defined orientation, which would allow the
development of force in privileged location and direction.
In the absence of VASP, the growing filament ends are
randomly oriented, leading to the formation of disorga-
nized actin clouds from which a productive force against
the bacterium wall cannot result. The EVH2 domain of
Ena has been proposed recently to be involved in multi-
merization of Ena (Ahern-Djamali et al., 1998). In view of
the present data showing the interaction of EVH2 with ac-
tin, it is also possible that F-actin was present as a third
Figure 9. Working model for the role
of VASP in actin-based motility. This
scheme summarizes the conclusions
from the present work concerning the
role of VASP in Listeria movement.
Step 0 represents nucleation of actin
filaments on Arp2/3 complex in inter-
action with the NH2-terminal domain
of ActA. VASP (V) is bound to the
central proline-rich repeats of ActA by
its EVH1 domain and binds to the side
of the growing filament by its EVH2
domain. Barbed end growth occurs from
G-actin and from profilin (P)-actin
complex. Capping of detached fila-
ments by the capping protein (C) and
cross-linking by a-actinin (x) is repre-
sented. Cycles of attachment–detach-
ment of VASP to and from actin fila-
ments allow insertional polymerization
of actin or profilin-actin and move-
ment as described in steps 1, 2, and 3.
Insertion of subunits at the barbed end
of cross-linked filaments generates
compression forces used for propul-
sion.Laurent et al. VASP and Actin-based Motility of Listeria 1257
partner serving to mediate or stabilize the interaction.
More detailed investigations will have to be carried out to
address this possibility.
The present data lead us to formulate the following
model. During Listeria movement, VASP remains located
at the bacterium–actin tail interface, implying that while
the EVH1 domain is bound to ActA, the EVH2 domain
slides along the side of the barbed end of the growing fila-
ment, allowing insertional polymerization of actin. This
working model of a molecular ratchet is illustrated in Fig.
9. Within this model, in maintaining the site of filament
growth at a defined location and distance from the bac-
terium surface, each added subunit would contribute in
pushing the bacterium, hence VASP would increase the
yield of the transformation of actin polymerization into
propulsive force. Since statistically all filaments do not at-
tach and detach simultaneously, considering the collective
behavior of the population of filaments assembled at the
bacterium surface is essential in understanding the mech-
anism of movement. Factors controlling the strength of
VASP interaction with actin, i.e., the frequency of attach-
ment–detachment steps, are expected to regulate the fila-
ment sliding rate, hence to control the speed of propulsion
of Listeria. The fact that the affinity of VASP for F-actin is
increased 40-fold (up to 0.5 3 108 M21) by phosphoryla-
tion of serine 157 raises the possibility that cAMP-depen-
dent phosphorylation of VASP slows down the movement
of Listeria. This possibility is currently under investigation.
Our data and conclusions compare well with those derived
from a recent study (Aszodi et al., 1999) showing that
VASP-null platelets aggregate faster. This observation sug-
gests that the role of VASP, which would be enhanced by
phosphorylation, could be in part, via actin binding, to main-
tain the cohesive integrity of the membrane actin cytoskel-
eton of unstimulated platelets. In conclusion, the use of selec-
tively depleted platelet and brain extracts provides a useful
tool for elucidating the role of Ena/VASP family proteins
in Listeria motility and in normal cellular function.
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